Back to Search Start Over

A multi-omics approach to investigate the inflammatory response to life course socioeconomic position

Authors :
Castagné, R.
Kelly-Irving, M.
Krogh, V.
Palli, D.
Panico, S.
Sacerdote, C.
Tumino, R.
Hebels, D.G.A.J.
Kleinjans, J.C.S.
De Kok, T.M.C.M.
Georgiadis, P.
Kyrtopoulos, S.A.
Vermeulen, R.
Stringhini, S.
Vineis, P.
Chadeau-Hyam, M.
Delpierre, C.
IRAS OH Epidemiology Chemical Agents
dIRAS RA-2
RS: MERLN - Instructive Biomaterials Engineering (IBE)
CBITE
RS: MERLN - Cell Biology - Inspired Tissue Engineering (CBITE)
Toxicogenomics
RS: GROW - R1 - Prevention
RS: FSE MaCSBio
RS: FPN MaCSBio
RS: FHML MaCSBio
Division Instructive Biomaterials Eng
Cancer Research UK
Commission of the European Communities
IRAS OH Epidemiology Chemical Agents
dIRAS RA-2
Source :
Epigenomics, 12(15), 1287-1302. Future Medicine Ltd., Epigenomics, Vol. 12, No 15 (2020) pp. 1287-1302, Epigenomics, 12(15). Future Medicine Ltd.
Publication Year :
2020

Abstract

Aim: Inflammation represents a potential pathway through which socioeconomic position (SEP) is biologically embedded. Materials & methods: We analyzed inflammatory biomarkers in response to life course SEP by integrating multi-omics DNA-methylation, gene expression and protein level in 178 European Prospective Investigation into Cancer and Nutrition-Italy participants. Results & conclusion: We identified 61 potential cis acting CpG loci whose methylation levels were associated with gene expression at a Bonferroni correction. We examined the relationships between life course SEP and these 61 cis-acting regulatory methylation sites individually and jointly using several scores. Less-advantaged SEP participants exhibit, later in life, a lower inflammatory methylome score, suggesting an overall increased expression of the corresponding inflammatory genes or proteins, supporting the hypothesis that SEP impacts adult physiology through inflammation.

Details

Language :
English
ISSN :
17501911
Database :
OpenAIRE
Journal :
Epigenomics, 12(15), 1287-1302. Future Medicine Ltd., Epigenomics, Vol. 12, No 15 (2020) pp. 1287-1302, Epigenomics, 12(15). Future Medicine Ltd.
Accession number :
edsair.doi.dedup.....632b3cd1cf1f16877c3ec1d43da58716